BARCLAYS PLC - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$97
-97.1%
20,986
-96.0%
0.00%
-100.0%
Q2 2023$3,397
-13.5%
525,964
+1.0%
0.00%0.0%
Q1 2023$3,925
+22.2%
520,521
+64.2%
0.00%
+100.0%
Q4 2022$3,211
-99.9%
317,028
+34.1%
0.00%
-66.7%
Q3 2022$2,338,000
-9.0%
236,398
-2.0%
0.00%
+50.0%
Q2 2022$2,569,000
+6.2%
241,228
-2.8%
0.00%0.0%
Q1 2022$2,418,000248,0700.00%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders